Accession Number: | 0001666071-20-000135 |
Date: | 2020-05-19 |
Issuer: | CARDLYTICS, INC. (CDLX) |
Original Submission Date: |
GRIMES SCOTT D.
C/O CARDLYTICS, INC.
675 PONCE DE LEON AVENUE NE, SUITE 6000
ATLANTA, GA 30308
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2020-05-19 | S | 2,000 | d | $60.00 | 129,112 | indirect | f2 | |
COMMON STOCK | 2020-05-19 | 0 | $0.00 | 214,431 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | this sale was effected pursuant to a rule 10b5-1 trading plan adopted by the trustee of the 2013 scott grimes grat uad (the "grat") on november 15, 2019, as amended march 12, 2020. |
f2 | the reportable securities are held by the grat. |